Androgenetic alopecia: a review

@article{Lolli2017AndrogeneticAA,
  title={Androgenetic alopecia: a review},
  author={Francesca Lolli and Francesco Pallotti and Alfredo Rossi and Maria Caterina Fortuna and Gemma Caro and Andrea Lenzi and Andrea Sansone and Francesco Lombardo},
  journal={Endocrine},
  year={2017},
  volume={57},
  pages={9-17}
}
PurposeAndrogenetic alopecia, commonly known as male pattern baldness, is the most common type of progressive hair loss disorder in men. The aim of this paper is to review recent advances in understanding the pathophysiology and molecular mechanism of androgenetic alopecia.MethodsUsing the PubMed database, we conducted a systematic review of the literature, selecting studies published from 1916 to 2016.ResultsThe occurrence and development of androgenetic alopecia depends on the interaction of… Expand

Paper Mentions

LITERATURE REVIEW Update Treatment of Male Androgenetic Alopecia
Background: Male androgenetic alopecia (MAGA), also known as androgenetic alopecia, is the most common hair loss in males who have a genetic predisposition. The pattern of baldness in MAGA startsExpand
Androgenetic Alopecia as a Marker of Metabolic Syndrome
Background: Alopecia induced by androgens in genetically predisposed individuals is termed as Androgenetic alopecia (AGA). There is proof appearance the relationship between Androgenetic alopecia andExpand
Evaluation of Serum Amyloid A3 in Young Adult Males with Early Onset of Androgenic Alopecia
TLDR
It was found that the patients with grade III and IV androgenetic alopecia with family ancestry of heart illnesses and raised lipid profile levels had critical height of serum amyloid A3 than different gatherings. Expand
Pharmacological therapeutics in androgenetic alopecia
© Korean Medical Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/3.0)Expand
A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors.
TLDR
An evidence-based pathogenesis model is proposed that attempts to answer the above questions, account for additionally-suspected androgenic alopecia mediators, identify rate-limiting recovery factors, and elucidate better treatment targets, and makes sense of dihydrotestosterone's paradoxical role in hair loss and hair growth. Expand
Mechanism of androgenic alopecia: Addressing speculations through empirical evidences
TLDR
A deep insight is presented of the major triggers of AGA, it's aetiologies and major anatomical and physiological changes while developing AGA, and a thorough and a clear understanding of the mechanism involved in AGA, its treatment, and major treatment targets are highlighted. Expand
Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort
TLDR
Early-onset androgenetic alopecia primarily affects male patients between 21–30 years of age and is likely to have inherited AGA from their fathers. Expand
Decreased expression of cytokeratin 15 and tropoelastin in men with androgenetic alopecia and its relationship with increased expression of p15/p16
TLDR
The results suggest that patients with AGA suffer tissue damage that affects different components of hair follicle stem cells as well as the extracellular matrix itself. Expand
Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
TLDR
Topical finasteride is a promising therapeutic option for the treatment of male AGA and female pattern hair loss and the importance of continued research for the establishment of a novel therapeutic agent is emphasized. Expand
Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function
TLDR
Finasteride is associated with significant seminological and testosterone alterations, but no sexual dysfunctions were reported during treatment of these andrologically healthy subjects and it is advisable to perform a careful andrological evaluation before treatment. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Enzymology of the hair follicle.
  • R. Hoffmann
  • Medicine
  • European journal of dermatology : EJD
  • 2001
TLDR
Current information about the androgen metabolism in hair follicles is reviewed and the potential impact on future therapeutic approaches is discussed. Expand
A mouse model of androgenetic alopecia.
TLDR
The hypothesis that androgen-mediated hair loss is AR dependent and suggest that AR and beta-catenin mediate this effect are supported and can now be used to test new therapeutic agents for the treatment of AGA, accelerating the drug discovery process. Expand
Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
TLDR
A large-scale meta-analysis of seven genome-wide association studies for early-onset AGA in 12,806 individuals of European ancestry identified a risk allele at 17q21.31 that was recently associated with Parkinson's disease (PD), providing important insights into the pathophysiology of these conditions. Expand
Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla.
TLDR
The enhanced expression of type II 5α-reductase, AR and Hic-5/ARA55 can upregulate sensitivity to androgen of dermal papilla cells in AGA, indicating that TGF-β1 is one of the key players in pathogenesis of AGA. Expand
EDA2R is associated with androgenetic alopecia.
TLDR
An epidemiological survey for AGA and case-control association analysis on the X chromosome identified Xq11-q12 as strongly associated with AGA, and statistical analysis carried out by conditioning each gene to the presence of the other showed that the association with EDA2R is independent while the associationWith AR seems to be the result of linkage disequilibrium. Expand
Androgen Receptor Copy Number Variation and Androgenetic Alopecia: A Case-Control Study
TLDR
The results suggest this form of genomic variation at the AR locus is unlikely to predispose to AGA, and thus no evidence of significant association between AGA and AR CNV is found. Expand
Genetic Analysis of Male Pattern Baldness and the 5α-Reductase Genes
TLDR
The findings suggest that the genes encoding the two 5α-reductase isoenzymes are not associated with male pattern baldness. Expand
Genetic analysis of male pattern baldness and the 5alpha-reductase genes.
TLDR
The findings suggest that the genes encoding the two 5alpha-reductase isoenzymes are not associated with male pattern baldness. Expand
EVIDENCE BASED ( S 3 ) GUIDELINES FOR THE TREATMENT OF ANDROGENETIC ALOPECIA IN WOMEN AND IN MEN
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair lossExpand
Male androgenetic alopecia (Part II)
TLDR
Substantial efforts have been undertaken to refine the methods used to evaluate therapeutic response and define acceptable primary and secondary endpoints for clinical trials. Expand
...
1
2
3
4
5
...